National Numeracy Day 2024: making maths work for women and girls

May 22, 2024

Written by Abby Paine, Hollie Pilkington, and Dom Partridge

 

Two years ago we wrote a blog for National Numeracy Day 2022, and enjoyed the process so much that we thought we would write another one! Last time, we wrote about network meta-analyses (a statistical method we use quite a lot here at Source), but this year we thought we’d introduce you to some of the women in our teams, who use maths as a key part of their everyday jobs. We have female colleagues working in both the health economics and statistics teams – in fact they make up 50% of the staff in those teams!

All of our health economists and statisticians play a key role in the launch of new medical treatments. For any new medicine to be approved for use in a particular disease, it must be more effective and at least as safe as an existing successful treatment (or a placebo). Statisticians review the available clinical trial data to determine whether a new treatment is better due to a placebo effect, or whether the additional benefit is real. Health economists use maths to consider how the effectiveness of the treatment compares with its cost, which is really important because while healthcare services around the world want the best treatment for their patients, they are constrained by budget pressures and need to determine what is the best use of their budgets when they have so many patients to treat.

One of the focuses for this year’s National Numeracy Day is making maths work for women and girls. We spoke to some of our female team members to get an insight into their experiences and hope this might encourage other women (and everyone!) to get into maths because it gives you so many career options:

 

 

If you are interested in exploring a career in health economics and market access, consider connecting with the Economic Modelling and Data Analysis team at Source Health Economics; we specialise in evidence generation, health economics, and communication.

More Insights

Language restrictions in systematic literature reviews: a reflection on the current tone

Language restrictions in systematic literature reviews: a reflection on the current tone

Written by Alys Ridsdale, Associate Systematic Review Analyst   Introduction There are over 7,100 spoken languages across the globe (1). Despite this linguistic diversity, including language restrictions in a systematic literature ... Read more

What are the implications of joint clinical assessment (JCA) on systematic reviews?

What are the implications of joint clinical assessment (JCA) on systematic reviews?

This article offers a overview of the challenges and strategies for navigating the upcoming EU JCA process, focusing on managing PICOS criteria and deadlines in clinical systematic literature reviews (SLRs). Read more

The European Union Joint Clinical Assessment (EU JCA) – an overview

The European Union Joint Clinical Assessment (EU JCA) – an overview

This article offers a brief overview of the EU JCA process and is the first in a series of articles where we will discuss the new process and implications for HTA developers. Read more

Pros and cons of crowdsourcing for systematic review

Pros and cons of crowdsourcing for systematic review

Written by Ciara Thomas, Vicky Crowe, & David Pritchett   Introduction To achieve optimal patient outcomes, systematic literature reviews (SLRs) must synthesise high quality, contemporary evidence to inform health policy and ... Read more